The Strongest Mental Health Parity Rules Ever Written Were Suspended Before They Took Effect

The Mental Health Parity and Addiction Equity Act — MHPAEA — was signed into law in October 2008. Its premise was direct: if a health insurer covers mental health and substance use disorder services, it must do so on terms no more restrictive than how it covers comparable medical and surgical care.

In practice, enforcement proved difficult from the start. Quantitative limits — annual session caps, day limits — were relatively easy to compare and prohibit. But insurers quickly learned that the same rationing effect could be achieved through "nonquantitative treatment limitations" (NQTLs): prior authorization requirements applied more broadly to behavioral health than to medical care, narrower provider networks, lower reimbursement rates structured to shrink in-network availability, and step-therapy protocols requiring multiple treatment failures before covering the recommended first-line option.

NQTLs don't appear in any single line item that a regulator can straightforwardly compare. They require analysis across the full benefit design, and their effects are only visible in aggregate — denial rates, authorization processing times, network adequacy ratios. After more than a decade of mounting evidence that NQTLs had become the primary vehicle for behavioral health discrimination, the Biden administration spent several years building a regulatory framework that would force insurers to prove parity in outcomes, not just on paper.

The 2024 Final Rule was published on September 23, 2024 — the most significant update to MHPAEA implementation since the original 2013 framework. Where the 2013 rule required comparative analyses of treatment limitations, the 2024 rule required those analyses to demonstrate actual parity in outcomes. The difference is substantial.

Four provisions defined what made the 2024 rule stronger than anything that had come before:

• Meaningful benefits requirement. Plans would have to ensure that behavioral health benefits are "meaningful" across all benefit classifications — not technically present but structured so restrictively as to be effectively inaccessible. A plan that covers inpatient psychiatric care in theory, but sets prior authorization thresholds so high that approvals are routinely denied at the same clinical acuity that would receive automatic approval for a comparable medical admission, would fail this standard.

• Outcomes-based testing. Plans would have to evaluate whether their NQTL practices produce parity in practice — comparing actual prior authorization approval rates, denial rates, network adequacy ratios, and out-of-network utilization data for behavioral health versus medical/surgical benefits. If the data showed disparate outcomes, the plan would be required to identify and correct the cause. This was the provision that most directly targeted the insurance industry's existing NQTL practices.

• Fiduciary certification. Plan fiduciaries would be required to formally certify that their NQTL comparative analyses meet the rule's standards — creating direct personal accountability for parity compliance at the plan-sponsor level rather than allowing it to be delegated without accountability to third-party administrators.

• Prohibition on using historical data. Plans could not use historical underutilization of behavioral health benefits as justification for restrictive access policies. This closed a circular logic loop: a plan couldn't point to low past utilization of a covered service as evidence that a restrictive NQTL was appropriate, when the low utilization was itself caused by the restrictive NQTL.

Implementation was staged: certain provisions were set to take effect January 1, 2025, with additional requirements phasing in January 1, 2026. The 2024 Final Rule was, by design, the regulatory backstop that would have forced the outcomes-level accountability that fifteen years of weaker parity enforcement had failed to achieve.

On January 17, 2025, the ERISA Industry Committee (ERIC) — an association representing large employers who sponsor self-insured group health plans — filed suit in the U.S. District Court for the District of Columbia challenging the validity of the 2024 Final Rule.

ERIC's core argument: the "meaningful benefits" standard is too vague to implement; the outcomes-based testing provisions exceed what MHPAEA's statutory text authorizes; and the fiduciary certification requirements create compliance obligations Congress never sanctioned. The complaint also challenged the tight implementation timeline, arguing that plans were given insufficient runway to redesign benefit structures to comply with requirements whose standards weren't yet fully defined.

The Trump administration's response was to move for abeyance — a request to the court to pause the litigation while the administration pursued non-enforcement. The court granted the abeyance request on May 12, 2025. Three days later, on May 15, 2025, the Departments of Labor, Health and Human Services, and Treasury jointly announced they would not enforce the 2024 Final Rule, "or otherwise pursue enforcement actions, based on a failure to comply that occurs prior to a final decision in the litigation, plus an additional 18 months."

The agencies simultaneously signaled that they may rescind or substantially modify the 2024 rule through formal rulemaking, though no NPRM had been published as of mid-2026. The combined effect: a rule that took years to develop, and which represented the most aggressive federal parity enforcement posture in MHPAEA's history, was suspended before its first compliance deadline passed.

The enforcement pause is specific — it applies to provisions that are "new in relation to the 2013 final rule." The 2013 framework, and the underlying statutory obligations of MHPAEA as amended by the Consolidated Appropriations Act of 2021, remain fully in effect. Insurers cannot simply disregard parity requirements. They can disregard the stronger 2024 requirements. The distinction matters:

Provision	Status
Meaningful benefits requirement	Paused — not enforceable
Outcomes-based NQTL testing with presumptions of non-compliance	Paused — not enforceable
Formal fiduciary certification of NQTL analyses	Paused — not enforceable
Prohibition on using historical data in NQTL analyses	Paused — not enforceable
Requirement to conduct and document NQTL comparative analyses	Active — 2013 rule applies
Plans must produce NQTL analyses for Departments or plan participants upon request	Active — still required
45-day corrective action requirement when non-compliance is found	Active — still required
Core MHPAEA statutory obligations (as amended by CAA 2021)	Active — always in force

What this means in practice: insurers are still required to perform and document comparative analyses showing that their NQTLs don't impose greater restrictions on behavioral health benefits than on comparable medical/surgical benefits. They're still required to provide those analyses to the DOL or CMS upon request, and to plan participants upon request. What they're no longer accountable for — for now — is proving parity through outcomes data rather than process documentation.

The 2025 Mental Health Parity Report to Congress (covering August 2023 through July 2025) illustrated what enforcement under the surviving 2013 framework looks like: EBSA issued 42 requests for comparative analyses across 28 investigations; CMS issued 43 comparative analysis letters across 43 investigations. The agencies found that plans frequently submitted incomplete or inadequate analyses, with CMS repeatedly finding "there was no comparative analysis" at all. The enforcement mechanism still exists — its teeth have been pulled back to 2013 standards.

The practical stakes of the enforcement pause are clearest when you look at what parity was designed to address at the level individual therapists experience: the systematic undercompensation of mental health services relative to comparable medical care.

According to Thrizer's 2025 private practice report, therapists accepting commercial insurance receive an average in-network reimbursement of approximately $111–$112 per session. Therapists operating on private-pay rates earn an average of $159 per session — a 36% premium for identical clinical work. Therapists who set their own private-pay rate report targeting $180–$200 per session.

The American Psychological Association's 2024 member survey found that approximately one-third of practicing psychologists no longer accept any insurance, and among those who had left insurance panels, 82% cited insufficient reimbursements as a primary reason. Administrative burden — prior authorization workflows, documentation requirements, payment delays, and clawback disputes — was cited by 62%.

Network adequacy data from the 2025 Parity Report frames the access consequence: surveys cited in the report found that behavioral health providers are available in 8–28% fewer network slots than comparable medical/surgical providers, despite equivalent or higher demand. The result is a market where patients who theoretically have behavioral health coverage face effective access barriers: long waits, out-of-network costs, or simply no available in-network providers in their area.

The 2024 Final Rule's outcomes-based testing provisions were specifically designed to surface and require correction of this pattern. A network adequacy disparity of the kind documented in the 2025 report — fewer behavioral health providers available in-network compared to medical/surgical — would have triggered a compliance obligation under the 2024 rule's framework. Under the suspended provisions, it does not.

The enforcement pause doesn't eliminate your rights or your patients' rights under existing parity law. The 2013 rule and the MHPAEA statute remain fully in force. That creates concrete levers for therapists navigating the current framework:

Request the NQTL comparative analysis. Under the 2013 rule and surviving provisions of the 2024 framework, insurers must produce their NQTL comparative analyses upon request. If you believe an insurer is applying more restrictive prior authorization requirements, narrower network standards, or lower reimbursement rates to behavioral health services than to comparable medical services, you — or your patients, or your patients' employers — can formally request the analysis. The 45-day corrective action requirement still applies once a non-compliance finding is made.

Document patient denials systematically. If your patients face insurance denials for mental health services, encourage formal appeals and request written denial explanations that cite the specific NQTL being applied. Denial records that demonstrate systematic disparities between behavioral health and medical/surgical claim processing are the primary evidence base for DOL and CMS enforcement actions — and for private civil litigation under MHPAEA, which remains an independent legal avenue. Each documented denial is a data point in a larger accountability picture that professional associations and state insurance commissioners are actively building.

Know your state's parity law. Twenty-five states have enacted mental health parity laws that are more stringent than the federal baseline. Some state laws impose quantitative requirements — minimum reimbursement rate floors, specific network adequacy ratios, or prior authorization time limits — that are not subject to the federal enforcement pause. The enforceability of state parity law varies considerably, but state insurance commissioners retain authority to enforce state-level requirements independently of federal agency action.

Track the litigation calendar. ERIC v. Department of Labor is still active in the U.S. District Court for D.C. A court ruling invalidating the 2024 Final Rule would make the suspension permanent through the legal pathway. A ruling upholding the rule would start the enforcement clock at 18 months after final decision. The litigation outcome — or a formal agency rescission proceeding — will determine whether the 2024 framework survives in any form.

There is a broader paradox at work that the enforcement pause highlights rather than creates. Mental health coverage in the United States has expanded substantially in both reach and mandate over the past two decades. MHPAEA created parity requirements. The Affordable Care Act made behavioral health an essential benefit in individual and small-group plans. The Consolidated Appropriations Act of 2021 strengthened the NQTL comparative analysis requirement. State legislatures have added their own requirements. On paper, more Americans have mental health coverage than at any point in history.

At the same time, the supply of therapists willing to participate in insurance networks is shrinking. Regional surveys consistently find double-digit shares of therapists who left panels in the past five to seven years, with substantial shares planning to leave soon. The Thrizer 2025 report found that only 8% of therapists now operate entirely on insurance — 32% are fully private-pay, and 60% use hybrid models that combine some insurance participation with a private-pay tier.

The mismatch between coverage mandates and provider participation is the defining structural tension in behavioral health access. Coverage expansion created demand. Reimbursement rates that haven't kept pace with operating costs, combined with administrative burden, created the conditions for supply contraction. The 2024 Final Rule's outcomes-based testing provisions were the regulatory mechanism designed to close this loop by creating accountability for the network adequacy and reimbursement disparities that are driving providers out. With those provisions suspended, the mechanism is broken.

The patients who bear the consequence are not primarily high-income individuals who can access private-pay care. They are the patients for whom insurance coverage is the difference between receiving care and not. The coverage that MHPAEA, the ACA, and successive legislation has guaranteed them is real — and in markets where no in-network therapists have availability, it is also not fully accessible.

For therapists thinking through practice economics, the enforcement pause is one more signal reinforcing a structural trend that has been building for years. The regulatory backstop that might have made insurance panel participation more financially sustainable — by requiring outcomes-level parity accountability — has been suspended indefinitely. The gap between what insurers pay and what private-pay therapy commands hasn't narrowed; the mechanism that might have narrowed it has been removed from the regulatory toolkit.

This doesn't mean therapists who serve Medicare populations, low-income clients, or communities without realistic private-pay options should exit insurance panels. For those practices, panel participation is an ethical commitment that reimbursement arithmetic doesn't simply override. The calculus is also different for group practices with high volume and diversified payer mixes than for solo practitioners weighing hourly revenue against sustainable caseloads.

But for the growing share of therapists building practices that don't depend entirely on insurance reimbursement, the current regulatory environment reinforces rather than reverses the direction of the broader private-pay shift reshaping the industry. Building owned client acquisition channels — a website that ranks locally for your specialty, consistent Google review velocity, and presence in AI-powered search — creates a stream of inquiries from patients who arrive already seeking care, often at private-pay rates, and not through an insurance-dependent directory.

The compliance dimensions of therapy websites — HIPAA-compliant data handling for intake forms, properly structured BAA relationships with platform vendors, FTC-compliant marketing claims — remain unchanged by the parity enforcement pause. What changes is the economic context: insurance-dependent practice economics are under structural pressure from multiple directions, and the regulatory reform that was designed to improve them has been suspended.

WebsiteTherapy is built around the owned-channel infrastructure that makes that pressure manageable: a practice website with local SEO, AI discoverability, and a content engine that generates private-pay inquiries independently of what any federal agency enforces. See what's included, or explore how it specifically supports solo practice economics.